Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection
Dorota Białas-Niedziela
1
,
Andrzej Olechowski
1
,
Joanna Ciszewska
1
,
Iwona Świtka-Więcławska
1
,
Dariusz Kęcik
1
Department of Ophthalmology, Warsaw Medical University
Białas-Niedziela D, Olechowski A, Ciszewska J, Świtka-Więcławska I, Kęcik D. Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection. Klinika Oczna / Acta Ophthalmologica Polonica. 2016;118(1):11-17. doi:10.5114/ko.2016.71639.
APA
Białas-Niedziela, D., Olechowski, A., Ciszewska, J., Świtka-Więcławska, I., & Kęcik, D. (2016). Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection. Klinika Oczna / Acta Ophthalmologica Polonica, 118(1), 11-17. https://doi.org/10.5114/ko.2016.71639
Chicago
Białas-Niedziela, Dorota, Andrzej Olechowski, Joanna Ciszewska, Iwona Świtka-Więcławska, and Dariusz Kęcik. 2016. "Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection". Klinika Oczna / Acta Ophthalmologica Polonica 118 (1): 11-17. doi:10.5114/ko.2016.71639.
Harvard
Białas-Niedziela, D., Olechowski, A., Ciszewska, J., Świtka-Więcławska, I., and Kęcik, D. (2016). Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection. Klinika Oczna / Acta Ophthalmologica Polonica, 118(1), pp.11-17. https://doi.org/10.5114/ko.2016.71639
MLA
Białas-Niedziela, Dorota et al. "Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 118, no. 1, 2016, pp. 11-17. doi:10.5114/ko.2016.71639.
Vancouver
Białas-Niedziela D, Olechowski A, Ciszewska J, Świtka-Więcławska I, Kęcik D. Central corneal thickness and intraocular pressure before the intravitreal administration of ranibizumab and in the early period following the injection. Klinika Oczna / Acta Ophthalmologica Polonica. 2016;118(1):11-17. doi:10.5114/ko.2016.71639.
The aim of the study was to determine the differences in the central corneal thickness and intraocular pressure measured before intravitreal administration of ranibizumab and at 30 to 60 minutes after the injection. The intraocular pressure was analysed as a stand-alone parametre and in correlation with the central corneal thickness. 72 patients (144 eyes) were enrolled. The treated eyes were compared to the fellow, non-treated eyes. The mean central corneal thickness in a treated eye was 558 µm and 596 µm at baseline (before the injection) and after the injection, respectively (p< 0.05). The mean intraocular pressure not correlated to the central corneal thickness in a treated eye 15.29 mmHg and 16.83 mmHg at baseline and post-injection, respectively (p< 0.05). When assessed in correlation with the central corneal thickness, the intraocular pressure did not increase post-injection in the treated eyes.
